with pleased launch. making we Thank I'm are you, Science, days in along the Lisa. early progress report Health VOWST collaborators at Nestle great our of the to that
and breadth Eric are by the seen. HCP of we we have mentioned, As encouraged magnitude that demand highly
the to us the commercial profile data need received the confirms understanding setting years release our success. reception CDI we've with VOWST of X options performance knowledge-based, and consistent ago. is as nearly up has are first demand that better for of since for launch that Phase enormous The observed our present our and This our also three enthusiastic strategy, the execution
customer four during on focused a and positive period. areas very education optimizing been We've HCP early coverage, the Scaling hospital establishing outflow. experience, payer our efforts, creating launch
product First, and our I'll have deployed. Nestle teams facing been The early of June. education trained VOWST Xnd, commercially in became weeks available generating describe several demand FDA the were customer since quickly field sales Immediately the efforts. promoting HCP and field approval May HCP after VOWST, teams before
in on reminder, the sales also right a of Nestle teams teams. were earlier referenced XX-person midnight disease heels the focused As a we and have of filling gastroenterology are to We XXX fortunate saw comprised the two that and conference infectious DDW representatives hospital approval. field
theater of to to had The a key at significant attended including continues gastroenterology positive. booth. presence be a enthusiastic and profile well-manned reaction a product and highly We the VOWST that conference, large,
HCP our CDI, in and effective to highly encouraged that scalable, have that efficacy recurrence. impressive on mentioned option is a meeting finally one preventing the meets consistently their number
As demand HCP of the we our observed as reported efforts, Nestle Health of a by result and education following breadth us Science. to magnitude
are patient pool, And we Early demand including across the first HCPs to see. are their experiencing seeing recurrent demand importantly, which in very something in patients, across patients pleased recurrence. is use is broad we
pool patient and these patients as within is recall choosing very this that VOWST, CDI. are encouraging, the for HCPs first is largest The patient you may recurrent highly their
over are enrollment XXX gastroenterology audience seeing from remains and a of utilization and other across from are received from XX% unique as HCP prescribers XX, specialties. July prescription We a broad with approximately firms
also and patient need in call is not strong of provider VOWST awareness an high-end field umet which prescribers group communities. There team's on list, are the of who indicator a the the and is
that VOWST, typically a CDI early their prescribing HCP level. to more practice. in multiple which individual depth the at of Finally, This patients of moderate have have than patient very XXX the sign is given prescribed positive HCPs the XX exists VOWST prescribed volume,
and The experience providing for area focus patients is second a positive providers.
including our commercial enrollment effort, financial critical provides Our patient support. working VOWST robust patient and VOWST voyage been experience, into new team voyage a hub treatment a has of and convert to is high-class start. diligently component a The
are medical with exception new branded navigate As launch must early place, process. where in the during product prescriber payer the policies the period, any not
to skilled seek Our highly VOWST, and allow, treatment VOWST approvals team it eligible in patients. for that event but window takes the we drug providers for option than is longer offer the that for they at free patients a supporting
of expected of several we programs. we early programs assistance and financial are phase, providing this seeing patient is This our launch one in are assistance utilization
programs. the example, dispensed patient via new free were starts XX% drug XXX For of approximately our
can VOWST Our information The area building so who on engaging continues third efficiently to engagement, has Field from year build benefit possible. quickly approval. each and focus as coverage the extensive that pre-approval prior efforts as Team payer Payer executed exchange access patient payers the is during Nestle to
progress three reinforce compelling the for The stakeholders, to proposition important largest value the team is including the PBMs, VOWST. making is prioritizing most and
year. half this move We expect as the see to policies second coverage we issued of through
XXX period, the launch our we seeing through starts approximately of patient's early drug XX% are benefit. patient the new During reimbursed
fruit hospital and we hospital these XXXX. will the to selling team efforts continues outflow bear into Finally, efforts begin its enhance year to later this believe
payment for On for the approval technology a for add for treated of inpatient new reimbursement Included XXXX. this a used CMS in-tap in their related on note, patient's in issued inpatient setting. last VOWST final week or was rules the when
the in inpatient The result next of for payment receive this year. is that Medicare setting will VOWST extra treated hospitals patients any with
that We VOWST payment this pleased are CMS. additional from have received
the CMS of see to final technology considers that rule substantial over existing agency notes microbiome. the its clinical that the in in technologies importance restoring the gut improvement VOWST be they and a
We know that expect our the of will who that the additional received we of and near significant the inpatient proportion in VOWST setting not the a VOWST term. outpatient is number in in opportunity smaller do than in-tap result have patients patients
However, patients are undoubtedly sickest. for these who among the
has the CMS to a additional time that the a over result substantial utilization. inpatient We hospital recognized barrier that an pleased addressed in use are has could in-tap that approval Medicare chooses clinical the therapy for improvement. as financial believe that We
on experience Science, of along coverage, will we move Health demand, to continued summary, at hospital as results. optimization expect and education, early continue through payer these customer progress HCP We, collaborators front, experience, by are quarters. payer outflow, and on encouraged provider we see the the with we patient and of coming acceleration In Nestle the focus and highly our our
call quarter. I'll Now, to the for turn financials over cover our David to the
